• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number 9553
Device Problems Difficult to Advance (2920); Material Deformation (2976)
Patient Problems Pain (1994); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/24/2021
Event Type  malfunction  
Event Description
It was reported that the stent damage occurred and the patient experienced pain.The target lesion was located in a coronary artery.A 32 x 3.50 promus premier drug-eluting stent was advanced for treatment, but could not be delivered to the lesion.After withdrawing the device, the stent strut was found to be lifted and deformed resulting in increased pain, procedure time, and risk to the patient.The procedure was not completed.
 
Event Description
It was reported that the stent damage occurred and the patient experienced pain.The target lesion was located in a coronary artery.A 32 x 3.50 promus premier drug-eluting stent was advanced for treatment, but could not be delivered to the lesion.After withdrawing the device, the stent strut was found to be lifted and deformed resulting in increased pain, procedure time, and risk to the patient.The procedure was not completed.It was further reported that the 95% stenosed target lesion was located in the right coronary artery.The procedure was completed with another of same device.There were no patient complications and the patient status was stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS PREMIER
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key12628448
MDR Text Key276341128
Report Number2134265-2021-12730
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 11/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/13/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/15/2023
Device Model Number9553
Device Catalogue Number9553
Device Lot Number0026861990
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received10/15/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/15/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age76 YR
Patient SexMale
-
-